Archived articles

International vaccine access center

A person loads a syringe from a glass vial containing the Novavax vaccine while a promotional sign in the background reads 'Novavax'
COVID-19
What you need to know about the Novavax vaccine
Published June 16, 2022
Novavax uses a combination of spike proteins and an immune stimulant to provoke an immune response against the virus that causes COVID-19. Vaccine expert William Moss discusses its strengths and weaknesses ahead of its potential emergency use authorization.
Boxed Pfizer vaccines are shipped overseas
Q+A
Without global vaccinations, further variants ahead
Published Dec 21, 2021
Vaccine experts Anna Durbin and William Moss explain how vaccination prevents viral mutation, discuss remaining barriers to global vaccine access
Moderna vaccine vial, vaccine document card, and syringe
Q+A
What's behind Biden's booster vaccine plan?
Published Aug 20, 2021
Vaccine expert Bill Moss discusses the national vaccine booster plan announced by President Joe Biden and beginning in late September
Illustration of an unamused person, a vaccine syringe, and scribbles
Commentary
Pausing AstraZeneca vaccinations in Europe a 'tragic' decision
Published March 26, 2021
Bill Moss, director of International Vaccine Access Center, discusses the fallout of the decision of several European countries to pause AstraZeneca vaccinations